Balyasny Asset Management L.P. Purchases New Holdings in Prime Medicine, Inc. (NYSE:PRME)
Balyasny Asset Management L.P. purchased a new stake in Prime Medicine, Inc. (NYSE:PRME – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 16,342 shares of the company’s stock, valued at approximately $48,000. A number of other hedge funds […]
Balyasny Asset Management L.P. purchased a new stake in Prime Medicine, Inc. (NYSE:PRME – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 16,342 shares of the company’s stock, valued at approximately $48,000. A number of other hedge funds […]
